Table 4. Adjusted ORs (95% CI) for medication non-adherence at 6 months and cognitive impairment at 5 years.

Non-adherence at 6 months		Cognitive impairment at 5 years aOR (95% CI)a
		Including stroke survivors with probable aphasia			excluding stroke survivors with probable aphasia (n = 7)
		NINDS	p	MoCA	p	NINDS	p	MoCA	p
Prescription refills (PDC<80%)	Lipid modifiers	3.31 (0.35, 31.46)	.298	1.67 (0.17, 16.64)	.664	3.53 (0.34, 37.14)	.293	2.99 (0.21, 42.05)	.416
	Antihypertensives	0.57 (0.07, 4.34)	.583	0.69 (0.09, 5.28)	.718	0.25 (0.02, 3.34)	.298	0.38 (0.04, 3.64)	.402
	Antithrombotics	0.93 (0.19, 4.62)	.928	1.41 (0.23, 8.79)	.713	0.99 (0.16, 6.11)	.995	1.46 (0.20, 10.78)	.713
Self-report	MARS	1.12 (0.45, 2.75)	.814	0.62 (0.57, 1.54)	.307	1.62 (0.57, 4.62)	.366	0.81 (0.30, 2.15)	.666

^aadjusted for age, sex, stroke severity, Essen stroke risk score.